160. Measuring the Impact of PCR-based MRSA Nares Screening on Vancomycin Use and Duration of Vancomycin Among Pneumonia Patients at an Academic Medical Center

BACKGROUND: The benefits of PCR-based MRSA nares screening for de-escalation of pneumonia therapy are well-established. In late 2022, UNCMC introduced a PCR-based MRSA nares screen for inpatient use, replacing a chromogenic culture-based screen. The improved turnaround time of the PCR-based test was...

Descripción completa

Detalles Bibliográficos
Autores principales: Stromberg, Joseph, Jones, Travis, Mavrogiorgos, Nikolaos, Marx, Ashley H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679140/
http://dx.doi.org/10.1093/ofid/ofad500.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679140/
http://dx.doi.org/10.1093/ofid/ofad500.233

Ejemplares similares